The landscape of managing diabetes is advancing with the emergence of transdermal GLP-1 delivery . These convenient delivery systems offer a potentially less invasive alternative to injections for individuals managing diabetes mellitus type 2 . They deliver a GLP-1 agonist directly through the sk